BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17827015)

  • 1. Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
    Gilleron P; Wlodarczyk N; Houssin R; Farce A; Laconde G; Goossens JF; Lemoine A; Pommery N; Hénichart JP; Millet R
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5465-71. PubMed ID: 17827015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
    Bolchi C; Pallavicini M; Bernini SK; Chiodini G; Corsini A; Ferri N; Fumagalli L; Straniero V; Valoti E
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5408-12. PubMed ID: 21802946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors.
    Abuhaie CM; Ghinet A; Farce A; Dubois J; Gautret P; Rigo B; Belei D; Bîcu E
    Eur J Med Chem; 2013 Jan; 59():101-10. PubMed ID: 23207411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
    Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
    Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds.
    Straniero V; Pallavicini M; Chiodini G; Ruggeri P; Fumagalli L; Bolchi C; Corsini A; Ferri N; Ricci C; Valoti E
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2924-7. PubMed ID: 24821376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.
    Asoh K; Kohchi M; Hyoudoh I; Ohtsuka T; Masubuchi M; Kawasaki K; Ebiike H; Shiratori Y; Fukami TA; Kondoh O; Tsukaguchi T; Ishii N; Aoki Y; Shimma N; Sakaitani M
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1753-7. PubMed ID: 19217288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc.
    Huang CY; Stauffer TM; Strickland CL; Reader JC; Huang H; Li G; Cooper AB; Doll RJ; Ganguly AK; Baldwin JJ; Rokosz LL
    Bioorg Med Chem Lett; 2006 Feb; 16(3):507-11. PubMed ID: 16289818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.
    Abuhaie CM; Ghinet A; Farce A; Dubois J; Rigo B; Bîcu E
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5887-92. PubMed ID: 24054122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of imidazole-containing analogues of farnesyl pyrophosphate and evaluation of their biological activity on protein farnesyltransferase.
    Coudray L; de Figueiredo RM; Duez S; Cortial S; Dubois J
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):972-85. PubMed ID: 19555171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
    Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitors.
    Clark MK; Scott SA; Wojtkowiak J; Chirco R; Mathieu P; Reiners JJ; Mattingly RR; Borch RF; Gibbs RA
    J Med Chem; 2007 Jul; 50(14):3274-82. PubMed ID: 17555307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.
    Tanaka A; Radwan MO; Hamasaki A; Ejima A; Obata E; Koga R; Tateishi H; Okamoto Y; Fujita M; Nakao M; Umezawa K; Tamanoi F; Otsuka M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3862-3866. PubMed ID: 28666734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
    Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
    Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New protein farnesyltransferase inhibitors in the 3-arylthiophene 2-carboxylic acid series: diversification of the aryl moiety by solid-phase synthesis.
    Lethu S; Bosc D; Mouray E; Grellier P; Dubois J
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):163-71. PubMed ID: 22233543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.
    Gilleron P; Millet R; Houssin R; Wlodarczyk N; Farce A; Lemoine A; Goossens JF; Chavatte P; Pommery N; Hénichart JP
    Eur J Med Chem; 2006 Jun; 41(6):745-55. PubMed ID: 16647166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the synthesis of bisubstrate inhibitors of protein farnesyltransferase: Synthesis and biological evaluation of new farnesylpyrophosphate analogues.
    Duez S; Coudray L; Mouray E; Grellier P; Dubois J
    Bioorg Med Chem; 2010 Jan; 18(2):543-56. PubMed ID: 20036564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.